American Century Companies Inc Y M Abs Therapeutics, Inc. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$6.57 - $18.69 $114,022 - $324,364
17,355 Added 61.01%
45,799 $744,000
Q4 2023

Feb 13, 2024
BUY
$4.88 - $7.42 $138,806 - $211,054
28,444 New
28,444 $193,000
Q3 2023

Nov 13, 2023
BUY
$4.86 - $7.23 $41,737 - $62,091
8,588 Added 65.19%
21,761 $118,000
Q2 2023

Aug 14, 2023
BUY
$5.68 - $10.34 $74,822 - $136,208
13,173 New
13,173 $89,000

Others Institutions Holding YMAB

# of Institutions
106
Shares Held
24.5M
Call Options Held
40.3K
Put Options Held
400
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $487M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email